175 related articles for article (PubMed ID: 38490573)
1. The antimicrobial activity of innate host-directed therapies: A systematic review.
Shapira T; Christofferson M; Av-Gay Y
Int J Antimicrob Agents; 2024 May; 63(5):107138. PubMed ID: 38490573
[TBL] [Abstract][Full Text] [Related]
2. Combined chemical genetics and data-driven bioinformatics approach identifies receptor tyrosine kinase inhibitors as host-directed antimicrobials.
Korbee CJ; Heemskerk MT; Kocev D; van Strijen E; Rabiee O; Franken KLMC; Wilson L; Savage NDL; Džeroski S; Haks MC; Ottenhoff THM
Nat Commun; 2018 Jan; 9(1):358. PubMed ID: 29367740
[TBL] [Abstract][Full Text] [Related]
3. Host-directed Therapy: A New Arsenal to Come.
Mohan M; Bhattacharya D
Comb Chem High Throughput Screen; 2021; 24(1):59-70. PubMed ID: 32723230
[TBL] [Abstract][Full Text] [Related]
4. Host-directed therapies for bacterial and viral infections.
Kaufmann SHE; Dorhoi A; Hotchkiss RS; Bartenschlager R
Nat Rev Drug Discov; 2018 Jan; 17(1):35-56. PubMed ID: 28935918
[TBL] [Abstract][Full Text] [Related]
5. The landscape of host transcriptional response programs commonly perturbed by bacterial pathogens: towards host-oriented broad-spectrum drug targets.
Kidane YH; Lawrence C; Murali TM
PLoS One; 2013; 8(3):e58553. PubMed ID: 23516507
[TBL] [Abstract][Full Text] [Related]
6. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM
mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748
[TBL] [Abstract][Full Text] [Related]
7. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
[TBL] [Abstract][Full Text] [Related]
8. Host-directed therapies for malaria: possible applications and lessons from other indications.
Adderley J; Grau GE
Curr Opin Microbiol; 2023 Feb; 71():102228. PubMed ID: 36395572
[TBL] [Abstract][Full Text] [Related]
9. Host-directed therapy against tuberculosis: Concept and recent developments.
Udinia S; Suar M; Kumar D
J Biosci; 2023; 48():. PubMed ID: 38088376
[TBL] [Abstract][Full Text] [Related]
10. Host Directed Therapy Against Infection by Boosting Innate Immunity.
Bergman P; Raqib R; Rekha RS; Agerberth B; Gudmundsson GH
Front Immunol; 2020; 11():1209. PubMed ID: 32595649
[TBL] [Abstract][Full Text] [Related]
11. Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance.
Watson K; Russell CD; Baillie JK; Dhaliwal K; Fitzgerald JR; Mitchell TJ; Simpson AJ; Renshaw SA; Dockrell DH
Front Immunol; 2020; 11():786. PubMed ID: 32582139
[TBL] [Abstract][Full Text] [Related]
12. Host-directed therapy to combat mycobacterial infections.
Kilinç G; Saris A; Ottenhoff THM; Haks MC
Immunol Rev; 2021 May; 301(1):62-83. PubMed ID: 33565103
[TBL] [Abstract][Full Text] [Related]
13. The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection.
Giraud-Gatineau A; Coya JM; Maure A; Biton A; Thomson M; Bernard EM; Marrec J; Gutierrez MG; Larrouy-Maumus G; Brosch R; Gicquel B; Tailleux L
Elife; 2020 May; 9():. PubMed ID: 32369020
[TBL] [Abstract][Full Text] [Related]
14. Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?
Steinstraesser L; Kraneburg UM; Hirsch T; Kesting M; Steinau HU; Jacobsen F; Al-Benna S
Int J Mol Sci; 2009 Sep; 10(9):3951-3970. PubMed ID: 19865528
[TBL] [Abstract][Full Text] [Related]
15. Novel approaches for the treatment of infections due to multidrug-resistant bacterial pathogens.
Imran M; Ahmad MN; Dasgupta A; Rana P; Srinivas N; Chopra S
Future Med Chem; 2022 Aug; 14(15):1133-1148. PubMed ID: 35861021
[TBL] [Abstract][Full Text] [Related]
16. Host-directed antimicrobial drugs with broad-spectrum efficacy against intracellular bacterial pathogens.
Czyż DM; Potluri LP; Jain-Gupta N; Riley SP; Martinez JJ; Steck TL; Crosson S; Shuman HA; Gabay JE
mBio; 2014 Jul; 5(4):e01534-14. PubMed ID: 25073644
[TBL] [Abstract][Full Text] [Related]
17. Host-directed therapies for antimicrobial resistant respiratory tract infections.
Maeurer M; Rao M; Zumla A
Curr Opin Pulm Med; 2016 May; 22(3):203-11. PubMed ID: 26989822
[TBL] [Abstract][Full Text] [Related]
18. An alloy of zinc and innate immunity: Galvanising host defence against infection.
von Pein JB; Stocks CJ; Schembri MA; Kapetanovic R; Sweet MJ
Cell Microbiol; 2021 Jan; 23(1):e13268. PubMed ID: 32975847
[TBL] [Abstract][Full Text] [Related]
19. AMPK in Pathogens.
Mesquita I; Moreira D; Sampaio-Marques B; Laforge M; Cordeiro-da-Silva A; Ludovico P; Estaquier J; Silvestre R
Exp Suppl; 2016; 107():287-323. PubMed ID: 27812985
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria.
Moravej H; Moravej Z; Yazdanparast M; Heiat M; Mirhosseini A; Moosazadeh Moghaddam M; Mirnejad R
Microb Drug Resist; 2018; 24(6):747-767. PubMed ID: 29957118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
